A new study has revealed that Restless Legs Syndrome (RLS) may be a possible biomarker for other underlying disease.
The study done by a nationally-recognized sleep expert found that patients with RLS have a higher mortality rate and are prone to cardiovascular diseases and hypertension.
Boston Medical Center neurologist Sanford H. Auerbach said that men with RLS were more likely to be diagnosed with lung disease, endocrine disease, diseases of nutrition and metabolism and immune system problems.
The study was published in Neurology the medical journal of the American Academy of Neurology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app